Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Luca Rapparini

Showing results (51-60 of 62) with videos related to

Pageof 7
Sort By:
Journal of the European Academy of Dermatology and Venereology : JEADV|October 27, 2023
Monkeypox: An Italian, multicentre study of 104 casesCarlo Alberto Maronese, Stefano Ramoni, Gianluca Avallone, et al.
Journal of the American Academy of Dermatology|July 22, 2025
Diagnosis and management of yellow nail syndrome: An international multi-institutional retrospective cohort study of 111 cases by an expert panelKaya L Curtis, Bianca Maria Piraccini, Michela Starace, et al.
Italian Journal of Dermatology and Venereology|October 3, 2025
Dermatological adverse events during hematological and oncological therapies (Bruton's tyrosine kinase inhibitors and mogamulizumab): an Italian retrospective multicenter studyMichela Starace, Stephano Cedirian, Luca Rapparini, et al.
Journal of the European Academy of Dermatology and Venereology : JEADV|February 3, 2025
Erosive pustular dermatosis of the scalp due to EGFR inhibitors: A multicentric study by EADV task force of 'Dermatology for Cancer Patients'Michela Starace, Luca Rapparini, Stephano Cedirian, et al.
Journal of the European Academy of Dermatology and Venereology : JEADV|February 11, 2026
Dermatologic adverse events associated with amivantamab: A multicentre studyVasiliki Nikolaou, Ander Mayor, Vincent Sibaud, et al.
JAMA Dermatology|December 23, 2024
Immune Checkpoint Inhibitor-Induced Vitiligo-Like DepigmentationMichela Starace, Stephano Cedirian, Luca Rapparini, et al.
Journal of the American Academy of Dermatology|January 10, 2024
Clinical outcomes and management of JAK inhibitor-associated acne in patients with moderate-to-severe atopic dermatitis undergoing upadacitinib: A multicenter retrospective studyGianluca Avallone, Luca Mastorino, Gianluca Tavoletti, et al.
Skin Appendage Disorders|October 9, 2025
Pediatric Pityriasis Amiantacea: A Multicenter Retrospective Study of 76 PatientsFelipe Tavares Rodrigues, Rita Fernanda Cortez de Almeida, Luciana Rodino Lemes, et al.
Dermatology and Therapy|April 23, 2025
Optimizing Tildrakizumab Dosing in Psoriasis: A 52-Week Multicenter Retrospective Study Comparing 100 mg and 200 mg-IL PSO (Italian Landscape Psoriasis)Mario Valenti, Luciano Ibba, Sara Di Giulio, et al.
Italian Journal of Dermatology and Venereology|May 29, 2024
Italian National Registry of Alopecia Areata: an epidemiological study of 699 Italian patientsBianca Maria Piraccini, Luca Rapparini, Federico Quadrelli, et al.
Pageof 7

Showing results (51-60 of 62) with videos related to

Sort By:
Pageof 7
Journal of the European Academy of Dermatology and Venereology : JEADV|October 27, 2023
Monkeypox: An Italian, multicentre study of 104 casesCarlo Alberto Maronese, Stefano Ramoni, Gianluca Avallone, et al.
Journal of the American Academy of Dermatology|July 22, 2025
Diagnosis and management of yellow nail syndrome: An international multi-institutional retrospective cohort study of 111 cases by an expert panelKaya L Curtis, Bianca Maria Piraccini, Michela Starace, et al.
Italian Journal of Dermatology and Venereology|October 3, 2025
Dermatological adverse events during hematological and oncological therapies (Bruton's tyrosine kinase inhibitors and mogamulizumab): an Italian retrospective multicenter studyMichela Starace, Stephano Cedirian, Luca Rapparini, et al.
Journal of the European Academy of Dermatology and Venereology : JEADV|February 3, 2025
Erosive pustular dermatosis of the scalp due to EGFR inhibitors: A multicentric study by EADV task force of 'Dermatology for Cancer Patients'Michela Starace, Luca Rapparini, Stephano Cedirian, et al.
Journal of the European Academy of Dermatology and Venereology : JEADV|February 11, 2026
Dermatologic adverse events associated with amivantamab: A multicentre studyVasiliki Nikolaou, Ander Mayor, Vincent Sibaud, et al.
JAMA Dermatology|December 23, 2024
Immune Checkpoint Inhibitor-Induced Vitiligo-Like DepigmentationMichela Starace, Stephano Cedirian, Luca Rapparini, et al.
Journal of the American Academy of Dermatology|January 10, 2024
Clinical outcomes and management of JAK inhibitor-associated acne in patients with moderate-to-severe atopic dermatitis undergoing upadacitinib: A multicenter retrospective studyGianluca Avallone, Luca Mastorino, Gianluca Tavoletti, et al.
Skin Appendage Disorders|October 9, 2025
Pediatric Pityriasis Amiantacea: A Multicenter Retrospective Study of 76 PatientsFelipe Tavares Rodrigues, Rita Fernanda Cortez de Almeida, Luciana Rodino Lemes, et al.
Dermatology and Therapy|April 23, 2025
Optimizing Tildrakizumab Dosing in Psoriasis: A 52-Week Multicenter Retrospective Study Comparing 100 mg and 200 mg-IL PSO (Italian Landscape Psoriasis)Mario Valenti, Luciano Ibba, Sara Di Giulio, et al.
Italian Journal of Dermatology and Venereology|May 29, 2024
Italian National Registry of Alopecia Areata: an epidemiological study of 699 Italian patientsBianca Maria Piraccini, Luca Rapparini, Federico Quadrelli, et al.
Pageof 7